DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Lowered to $19.00 at Wells Fargo & Company

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) had its price target reduced by investment analysts at Wells Fargo & Company from $20.00 to $19.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has an "equal weight" rating on the medical instruments supplier's stock. Wells Fargo & Company's target price would suggest a potential upside of 21.87% from the company's previous close.

A number of other equities analysts have also recently issued reports on XRAY. StockNews.com upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Tuesday, February 18th. Jefferies Financial Group downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating and reduced their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Mizuho started coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 price objective on the stock. Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $25.00 to $23.00 and set a "buy" rating for the company in a report on Friday. Finally, Leerink Partners lowered shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $23.58.

DENTSPLY SIRONA Trading Down 2.5 %

XRAY traded down $0.40 on Friday, hitting $15.59. 3,382,771 shares of the company were exchanged, compared to its average volume of 2,593,609. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The firm has a fifty day simple moving average of $18.77 and a two-hundred day simple moving average of $21.39. The stock has a market capitalization of $3.10 billion, a PE ratio of -7.53, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA has a 12 month low of $15.47 and a 12 month high of $34.28.

Insiders Place Their Bets

In other news, Director Gregory T. Lucier acquired 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The shares were bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. 0.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Allworth Financial LP boosted its holdings in DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock worth $59,000 after acquiring an additional 625 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in DENTSPLY SIRONA by 43.9% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,038 shares of the medical instruments supplier's stock worth $326,000 after buying an additional 3,671 shares in the last quarter. State of Alaska Department of Revenue grew its position in shares of DENTSPLY SIRONA by 2.4% during the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier's stock valued at $637,000 after acquiring an additional 560 shares during the period. US Bancorp DE grew its holdings in DENTSPLY SIRONA by 6.0% in the third quarter. US Bancorp DE now owns 59,553 shares of the medical instruments supplier's stock valued at $1,612,000 after purchasing an additional 3,397 shares during the period. Finally, Cambiar Investors LLC increased its holdings in DENTSPLY SIRONA by 3.3% in the 3rd quarter. Cambiar Investors LLC now owns 340,234 shares of the medical instruments supplier's stock worth $9,207,000 after acquiring an additional 10,862 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.